Références
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–1920.
Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s oesophagus: the Prague C & M criteria. gastroenterology 2006;131:1392–1399.
Boyer J, Laugier R, Chemali M, Arpurt JP, Boustière C, Canard JM, et al. French society of Digestive Endoscopy (sFED) guideline: monitoring of patients with Barrett’s oesophagus. Endoscopy 2007;39:840–842.
Cooper BT, Chapman W, Neumann CS, Gearty JC. Continuous treatment of Barrett’s oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006;23:727–733.
Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s oesophagus with dysplasia. N Engl J Med 2009;360:2277–2288.
Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–578.
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Robaszkiewicz, M., Vaillant, E. Surveillance de l’endobrachyœsophage et modalités thérapeutiques. Acta Endosc 41, 281–285 (2011). https://doi.org/10.1007/s10190-011-0198-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-011-0198-4